Dose Finding and Beyond in Biopharmaceutical Development

Dose Finding and Beyond in Biopharmaceutical Development
Author :
Publisher : Springer Nature
Total Pages : 267
Release :
ISBN-10 : 9783031671104
ISBN-13 : 3031671104
Rating : 4/5 (104 Downloads)

Book Synopsis Dose Finding and Beyond in Biopharmaceutical Development by : Jingjing Ye

Download or read book Dose Finding and Beyond in Biopharmaceutical Development written by Jingjing Ye and published by Springer Nature. This book was released on with total page 267 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Dose Finding and Beyond in Biopharmaceutical Development Related Books

Dose Finding and Beyond in Biopharmaceutical Development
Language: en
Pages: 267
Authors: Jingjing Ye
Categories:
Type: BOOK - Published: - Publisher: Springer Nature

GET EBOOK

Dose Finding and Beyond in Biopharmaceutical Development
Language: en
Pages: 0
Authors: Jingjing Ye
Categories: Medical
Type: BOOK - Published: 2024-11-01 - Publisher: Springer

GET EBOOK

This book covers topics in 2 parts: 1) Review of FDA Guidance, 2) Novel Designs and Analyses. While covering basic principles of dose finding, this book details
Genomics in Drug Discovery and Development
Language: en
Pages: 496
Authors: Dimitri Semizarov
Categories: Medical
Type: BOOK - Published: 2008-11-03 - Publisher: John Wiley & Sons

GET EBOOK

Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition an
Industrialization of Drug Discovery
Language: en
Pages: 324
Authors: Jeffrey S. Handen
Categories:
Type: BOOK - Published: 2021-06-30 - Publisher: CRC Press

GET EBOOK

The pharmaceutical industry suffers from an innovation deficit, with clinical attrition and safety-related market-withdrawal rates at the same level as twenty y
Target Validation in Drug Discovery
Language: en
Pages: 293
Authors: Brian W. Metcalf
Categories: Medical
Type: BOOK - Published: 2011-04-28 - Publisher: Elsevier

GET EBOOK

This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enab